Alteration of pregnancy related hormones and fetal survival in F-344 rats exposed by inhalation to benzo(a)pyrene

Reproductive Toxicology

Volumn 16, Issue 6, 2002, Pages 801-808

  Archibong, Anthony E ^a   Inyang, Frank ^a   Ramesh, Aramandla ^a   Greenwood, Michael ^a   Nayyar, Tultul ^a   Kopsombut, Prapaporn ^a   Hood, Darryl B ^a   Nyanda, Alfred M ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Benzo(a)pyrene; Fetus; Inhalation; Luteotropin; Polycyclic aromatic hydrocarbons; Pregnancy; Transplacental

Indexed keywords

BENZO[A]PYRENE; CARBON; ESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; PROGESTERONE; PROLACTIN;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; CORPUS LUTEUM; DOSE RESPONSE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ESTROGEN BLOOD LEVEL; FEMALE; FETUS DEATH; GESTATIONAL AGE; IATROGENIC DISEASE; INHALATIONAL DRUG ADMINISTRATION; LAPAROTOMY; LITTER SIZE; NEWBORN; NIDATION; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRENATAL EXPOSURE; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZATION; RAT; RAT STRAIN; SURVIVAL RATE; VEIN PUNCTURE;

ADMINISTRATION, INHALATION; ANIMALS; BENZO(A)PYRENE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO IMPLANTATION; EMBRYONIC DEVELOPMENT; ESTROGENS; FEMALE; FETAL DEATH; LITTER SIZE; MATERNAL EXPOSURE; PREGNANCY; PROGESTERONE; PROLACTIN; RATS; RATS, INBRED F344;

ANIMALIA; MARTES PENNANTI;

EID: 0036840793     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(02)00058-8     Document Type: Article

References (67)

1. Agency for Toxic Substances and Diseases Registry (ATSDR). Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs). Agency for Toxic Substances & Diseases Registry, US Department of Health and Human Services, US Public Health Service, Atlanta, GA, 1995. p. 271.
2. Boffetta P, Journekova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997;8:444-72.
3. DeJong WH, Kroese ED, Vos JG, Van Loveren H. Detection of immunotoxicity of benzo(a)pyrene in a subacute toxicity study after oral exposure in rats. Toxicol Sci 1999;50:214-20.
4. Hood DB, Nayyar T, Ramesh A, Greenwood M, Inyang F. Modulation in the developmental expression profile of Sp1 subsequent to transplacental exposure of fetal rats to desorbed benzo(a)pyrene following maternal inhalation. Inhal Toxicol 2001;12:511-35.
5. Hood DB, Nayyar T, Greenwood M, Ramesh A, Nunes M, Inyang F, et al. Subacute exposure of timed-pregnant rats to a benzo(a)pyrene: Carbon black aerosol; effects on development in the F1 generation-I. The Toxicologist 2001;60:275.
6. Ramesh A, Inyang F, Hood DB, Knuckles ME. Aryl hydrocarbon hydroxylase (AHH) activity in F-344 rats subchronically exposed to benzo(a)pyrene and fluoranthene (FLA) through diet. J Biochem Mol Toxicol 2000;3:155-61.
7. Ramesh A, Greenwood M, Inyang F, Hood DB. Toxicokinetics of inhaled benzo(a)pyrene: Plasma and lung bioavailability. Inhal Toxicol 2001a;13:533-55.
8. Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM. Metabolism, bioavailability, and toxicokinetics of benzo(a)pyrene in F-344 rats following oral administration. Exp Toxicol Pathol 2001;53:275-90.
9. Inyang F, Ramesh A, Hood DB, Greenwood M, Nunes MG, Kopsumbut P, et al. Disruption of testicular steroidogenesis and epididymal function by inhaled benzo(a)pyrene. The Toxicologist 2001;60:273.
10. 1 generation-II. The Toxicologist 2001;60:274.
11. Nayyar T, Ramesh A, Wu J, Greenwood M, Hood DB. Dysregulation of AhR, ARNT and CYP1A1 developmental expression profiles and effects on benzo(a)pyrene metabolism in F1 generation pups following sub-acute inhalation exposure of timed pregnant dams. The Toxicologist 2002;66:35.
12. Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicities of benzo(a)pyrene in F-344 rats. Toxicol Sci 2001;61:382-8.
13. Saunders C, Shockley DC, Knuckles ME. Behavioral effects induced by acute exposure to benzo(a)pyrene in F-344 rats. Neurotoxicity Res 2001;3:557-79.
14. Saunders CR, Ramesh A, Shockley DC. Modulation of neurotoxic behavior in F-344 rats by temporal disposition of benzo(a)pyrene. Toxicol Lett 2002;129:33-45.
15. Ramesh A, Hood DB, Inyang F, Greenwood M, Archibong AE, Knuckles ME. Comparative metabolism, bioavailability and toxicokinetics of benzo(a)pyrene in rats after acute oral, inhalation, and intravenous administration. Polycyclic Aromatic Compounds 2002;22:969-80.
16. Gurtoo HL, Williams CJ, Gottilek K, Mulhem AI, Caballes L, Vaught JB, et al. Population distribution of placental metabolism in smokers. Int J Cancer 1983;31:29-37.
17. Miller MM, Plowchalk DR, Weitzman GA, London SN, Mattison DR. The effect of benzo(a)pyrene on murine ovarian and corpora lutea volumes. Am J Obstet Gynecol 1992;166:1535-41.
18. MacMahon B, Trichopoulos D, Cole P, Brown J. Cigarette smoking and urinary estrogens. N Engl J Med 1982;307:1062-5.
19. Gibori G, Rothchild I, Pepe GJ, Morishige WK, Lam P. Luteotropic action of the decidual tissue in the rat. Endocrinology 1974;95:1113-8.
20. Castracane VD, Rothchild I. Luteotropic action of decidual tissue in the rat: Comparison of jugular and uterine vein progesterone level and the effect of ligation of the utero-ovarian connections. Biol Reprod 1976;15:497-503.
21. Basuray R, Gibori G. Luteotropic action of the decidual tissue in the pregnant rat. Biol Reprod 1980;23:507-12.
22. Gibori G, Kalison B, Basuray R, Rao MC, Hunzicker-Dunn M. Endocrine role of the decidual tissue: Decidual luteotropin regulation of luteal adenylyl cyclase activity, luteinizing hormone receptors, and steroidogenesis. Endocrinology 1984;115:1157-63.
23. Gibori G, Kalison B, Warshaw ML, Basuray R, Glaser LA. Differential action of decidual luteotropin on luteal and follicular production of testosterone and estradiol. Endocrinology 1985;116:1784-91.
24. Pepelko I, Withey JR. Methods for route-to-route extrapolation of dose. Toxicol Ind Health 1985;1:153-70.
25. Archibong AE, England DC, Stormshak F. Factors contributing to embryonic mortality in gilts bred at pubertal estrus. J Anim Sci 1987a;64:474-8.
26. Lioy PL, Waldman J, Harkov R, Pietarinen C. The total human environmental exposure study (THEES) to benzo(a)pyrene: Comparison of the inhalation and food pathways. Arch Environ Health 1988;43:304-12.
27. Kuller LH, Garfield L, Correa P, Haley N, Hoffmann A, Preston-Martin S, et al. Contribution of passive smoking to respiratory cancer. Environ Health Perspect 1986;70:57-69.
28. Lewtas J, Walsh D, Williams R, Dobias L. Air pollution exposure-DNA adduct dosimetry in humans and rodents: Evidence for non-linearity at high doses. Mutat Res 1997;378:51-63.
29. Chiang TA, Wu PF, Wang LF, Lee H, Lee CH, Ko YC. Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutat Res 1997;381:157-61.
30. Viau C, Hakizimana G, Bouchard M. Indoor exposure to polycyclic aromatic hydrocarbons and carbon monoxide in traditional houses in Burundi. Int Arch Occup Environ Health 2000;73:331-8.
31. Bui QQ, Tran MB, West WL. A comparative study of the reproductive effects of methadone and benzo(a)pyrene in the pregnant and pseudopregnant rat. Toxicology 1986;42:195-204.
32. Cervello I, Lafuente A, Giralt M, Mallol J. Enhanced glutathione S-transferase (GST) activity in pregnant rats treated with benzo(a)pyrene. Placenta 1992;13:273-80.
33. Mattison DR, White NB, Nightingale MR. The effect of benzo(a)pyrene on fertility, primordial oocyte number, and ovarian response to pregnant mare's serum gonadotropin. Pediat Pharmacol 1980;1:143-51.
34. Mackenzie KM, Angevine DM. Infertility in mice exposed in utero to benzo(a)-pyrene. Biol Reprod 1981;24:183-91.
35. Hansen JM, Reynolds PR, Booth GB, Seegmiller RE. Developmental toxicity of carbon black oil in mice. Teratology 2000;62:227-32.
36. Zhang L, Shiverick KT. Benzo(a)pyrene, but not 2,3,7,8-tetra-chlorodibenzo-p-dioxin alters cell proliferation and c-myc and growth factor expression in human placental choriocarcinoma cells. Biochem Biophys Res Commun 1997;231:117-20.
37. Li YL, Biggers WJ, Sanyal MK. Deleterious influence of maternal polynuclear aromatic hydrocarbon treatment on developing blood vascular system of fetuses in the rat. Teratology 1997;55:43.
38. Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect 2000;108:1159-64.
39. Holladay SD, Smith BJ. Fetal hematopoietic alterations after maternal exposure to benzo(a)pyrene: A cytometric evaluation. J Toxicol Environ Health 1994;42:259-73.
40. Lummus ZL, Henningsen G. Modulation of T-cell ontogeny by transplacental benzo(a)pyrene. Int J Immunopharmacol 1995;17:339-50.
41. McCabe DP, Flynn EJ. Deposition of low dose benzo(a)pyrene into fetal tissue: Influence of protein binding. Teratology 1990;41:85-95.
42. Byczkowski JZ, Kulkarni AP. Activation of benzo(a)pyrene 7,8-dihydrodiol in rat uterus: An in vitro study. J Biochem Toxicol 1990;5:139-45.
43. Iannaccone PM, Fahl WE, Stols L. Reproductive toxicity associated with endometrial cell mediated metabolism of benzo(a)pyrene, a combined invitro, invivo approach. Carcinogenesis 1984;5:1437-42.
44. Barbieri O, Ognio E, Rossi O, Astigiano S, Rossi L. Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice. Cancer Res 1986;46:94-8.
45. Wells PG, Obilo FC, de Morais SM. Benzo(a)pyrene embryopathy in rats genetically deficient in bilirubin UDP-glucuronyl transferase (GT). FASEB J 1989;3:A1025.
46. Huel G, Godin J, Frery N, Girard F, Moreau T, Nessmann C, et al. Arylhydrocarbon hydroxylase activity in human placenta and threatened preterm delivery. J Exp Anal Environ Epidemiol 1993;3(Suppl 1):187-99.
47. Perera FP, Whyatt RM, Jedrychowski W, Rauh V, Manchester D, Santella RM, et al. Adverse reproductive outcomes from exposure to environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol 1998;147:309-14.
48. Sram RJ, Binkova B, Rössner P, Rubeş J, Topinka J, Dejmek J. Adverse reproductive outcomes from exposure to environmental mutagens. Mutat Res 1999;428:203-15.
49. Archibong AE, England DC, Stormshak F. Ovulation and embryonic survival in GnRH treated pubertal gilts. Proc West Sec Am Soc Anim Sci 1986;37:20-2.
50. Archibong AE, England DC, Stormshak F. Ovulation and embryonic survival in pubertal gilts treated with gonadotropin releasing hormone. J Anim Sci 1987;65:752-5.
51. Archibong AE, Maurer RR, England DC, Stormshak F. Influence of sexual maturity of donor on invivo survival of transferred porcine embryos. Biol Reprod 1992;47:1026-30.
52. Nykamp JA, Bols NC, Carlson JC. Phenanthrenequinone disrupts progesterone production in rat luteal cells. Reprod Toxicol 2001;15:393-8.
53. Hutz RJ. Reproductive endocrine disruption by environmental xenobiotics that modulate the estrogen-signaling pathway particularly tetrachlorodibenzo-p-dioxin (TCDD). Rev J Reprod Develop 1999;45:1-12.
54. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994;266:1524-7.
55. Ebright RH, Wong JR, Chen LB. Binding of Z-hydroxybenzo(a)-pyrene to estrogen receptors in rat cytosol. Cancer Res 1986;46:2349-51.
56. Tran DQ, Ide CF, McLachlan JA, Arnold SF. The anti-estrogenic activity of selected polynuclear aromatic hydrocarbons in yeast expressing human estrogen receptor. Biochem Biophys Res Commun 1996;229:102-8.
57. Arcaro KF, O'Keefe PW, Yang Y, Clayton W, Gierthy JF. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 1999;133:115-27.
58. Fertuck KC, Matthews JB, Zacharewski TR. 3-Hydroxy benzo(a)-pyrene and 9-hydroxy benzo(a)pyrene are responsible for invitro estrogen receptor-mediated gene expression of benzo(a)pyrene, but do not elicit uterotropic effects in vivo. Toxicol Sci 2001;59:231-40.
59. Chaloupka K, Krishnan V, Safe S. Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: Role of the Ah receptor. Carcinogenesis 1992;13:2233-9.
60. Bouchard P. Progesterone and the progesterone receptor. J Reprod Med 1999;44:153-7.
61. Martin CR. Endocrine Physiology. New York: Oxford University Press, 1985. p. 1009.
62. Rao MC, Gibori G. Corpus luteum: Animal models of possible relevance to reproductive toxicology. Reprod Toxicol 1987;1:61-9.
63. Herz Z, Khan I, Jayatilak PG, Gibori G. Evidence for the synthesis and secretion of decidual luteotropin; a prolactin-like hormone produced by rat decidual cells. Endocrinology 1986;118:2203-9.
64. Gibori G, Jayatilak PG, Khan I, Rigby B, Puryear T, Nelson S, et al. Decidual luteotropin secretion and action: Its role in pregnancy maintenance in the rat. In: Mahesh VB, Dhindsa DS, Anderson M, Kalra SP, editors. Regulation of Ovarian and Testicular Function. New York: Plenum Press, 1987. p. 379-98.
65. Handwerger S, Freemark M. Role of placental lactogen and prolactin in human pregnancy. In: Mahesh VB, Dhindsa DS, Anderson M., Kalra SP, editors. Regulation of Ovarian and Testicular Function. New York: Plenum Press, 1987, p. 399-420.
66. Spencer F, Chi L, Zhu M. Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats. Comp Biochem Physiol C Toxicol Pharmacol 2001;129:25-34.
67. Gibori G, Basuray R, McReynolds B. Luteotropic role of the decidual tissue in the rat: Dependency on intraluteal estradiol. Endocrinology 1981;108:2060-6.